Skip to content

Insider · CIK 0001791222

Charles S. Coleman

officer

Files at OPLN (OPENLANE, Inc.). First filing Aug 8, 2025, latest Aug 8, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $1.7M sold

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
53Moderate
OPLNsell 2
OPENLANE, Inc.
$1.7M
59,289 shares
-64%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 7, 2025OPLN
OPENLANE, Inc.
MOption exercise
Common Stock
+39,526$13.81$546k93,000Aug 8, 2025
Aug 7, 2025OPLN
OPENLANE, Inc.
SOpen-market sale
Common Stock
-39,526$27.97$1.1M53,474Aug 8, 2025
Aug 7, 2025OPLN
OPENLANE, Inc.
MOption exercise
Common Stock
+19,763$13.81$273k73,237Aug 8, 2025
Aug 7, 2025OPLN
OPENLANE, Inc.
SOpen-market sale
Common Stock
-19,763$27.97$553k53,474Aug 8, 2025
Aug 7, 2025OPLN
OPENLANE, Inc.
MOption exercise
Employee Stock Option (right to buy)derivative
-39,526$13.81$546k39,526Aug 8, 2025
Aug 7, 2025OPLN
OPENLANE, Inc.
MOption exercise
Employee Stock Option (right to buy)derivative
-19,763$13.81$273k0Aug 8, 2025
May 9, 2025OPLN
OPENLANE, Inc.
MOption exercise
Common Stock
+15,000$0.00$057,880May 12, 2025
May 9, 2025OPLN
OPENLANE, Inc.
FTax withholding
Common Stock
-4,406$21.96$97k53,474May 12, 2025
May 9, 2025OPLN
OPENLANE, Inc.
MOption exercise
Restricted Stock Unitsderivative
-15,000$0.00$00May 12, 2025
Feb 21, 2025OPLN
OPENLANE, Inc.
AGrant or award
Restricted Stock Unitsderivative
+21,511$0.00$021,511Feb 25, 2025
Feb 19, 2025OPLN
OPENLANE, Inc.
AGrant or award
Common Stock
+6,853$0.00$045,155Feb 21, 2025
Feb 19, 2025OPLN
OPENLANE, Inc.
FTax withholding
Common Stock
-2,275$20.07$46k42,880Feb 21, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Charles S. Coleman: insider trades and track record | InsiderTell